Logo

drug development

Personalis, AstraZeneca Extend Collaboration Around Residual Cancer Detection Test

Personalis will use its NeXT Personal molecular residual disease assay to track emerging recurrence in at least one AstraZeneca drug trial.

Caris Life Sciences, ConcertAI Partner on Molecular Oncology R&D Platform

Caris and ConcertAI will combine their multiomic and multimodal databases and AI technology to create a unified platform for use in oncology and hematology.

Envisagenics, Cancer Research UK, Queen Mary University Collaborate on AML Drug R&D

Cold Spring Harbor spinout Envisagenics will apply its AI technology to multiomics data in pursuit of new therapies for acute myeloid leukemia and other hematopoietic cancers.

Envisagenics, Bristol Myers Squibb Partner to ID Cancer Therapy Alternative Splice Targets

Envisagenics will use its SpliceCore platform to identify alternative splicing-derived therapeutic targets for BMS's cancer pipeline.

Genomenon Partners With Neurodevelopmental Disease Groups on Drug Development

The Ann Arbor, Michigan-based bioinformatics company will provide AI-driven genomic data analysis in search of precision treatments for several rare pediatric disorders.

Jul 6, 2022

Guardant Health Licenses Genomic Cancer Assays to Adicon for Testing in China

Apr 5, 2022

Singlera Genomics, Astellas Pharma Partner to Study Drug Reactions

Mar 29, 2022

ImmunoPrecise Antibodies to Acquire BioStrand for €20M

Feb 8, 2022

Tempus Acquires Highline Sciences

Nov 11, 2021

Genomenon, Inozyme Collaborate on MDx Effort for ENPP1 Deficiency

Oct 25, 2021

UK Biobank WGS Consortium Describes 150K Genome Dataset at ASHG, Sets Sights on 500K
Premium

Oct 14, 2021

Caris Life Sciences, Ono Pharmaceutical Ink Cancer Drug Development Collaboration

Aug 16, 2021

Qlucore, Clarivate to Integrate Analytics Software for Multiomics Data

Jul 1, 2021

Cergentis Highlights TLA Tech in Lymphoma Study, Seeks Commercialization Partner
Premium

Jun 24, 2021

Indivumed Launches Bioinformatics Platform, Expands Cancer Drug Discovery Efforts
Premium

May 4, 2021

Bio-Techne, 908 Devices Partner on Protein Characterization

Apr 15, 2021

Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B

Mar 17, 2021

M2Gen Lands New Private Investment, Inks Research Deal with Merck

Feb 19, 2021

Cytosine Base Editors Allow Scientists to Study Function of Variants at Scale
Premium

Nov 5, 2020

Paradigm4 Moves Into Single-Cell Data, Helps Pharma Address COVID-19
Premium

Oct 1, 2020

Genuity Science, Ionis Pharmaceuticals Partner on Antisense Therapy Development

Aug 11, 2020

Syapse Expands FDA Collaboration to Include COVID-19 Impact on Cancer Care

Jul 13, 2020

Genuity Science, Formerly WuXi NextCode, Reinvents Itself With US, Europe Focus
Premium

Jun 10, 2020

10x Genomics, MilliporeSigma Collaborate on CRISPR Screening Workflow

Apr 21, 2020

Envisagenics to Bring RNA Splicing Software Platform to J&J Lung Cancer Initiative

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.